Overview

Oxygen Therapy for Retinal Ischemia

Status:
Withdrawn
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
The investigators will be using nocturnal normobaric hyperoxia therapy in patients with diagnoses of conditions related to retinal ischemia.
Phase:
Phase 4
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center